Composition and properties
UrgoTul® Absorb Border is an absorbent foam dressing with a silicone adhesive border and shower-proof backing. It is based on the exclusive and patented TLC (Technology Lipido-Colloid).
TLC at the heart, silicone at the border
Providing all the benefits of TLC (Technology – Lipido Colloid)
- Moist Wound Healing Environment (1,2)
- Increased stimulation of fibroblast proliferation (3,4)
- Promotes wound healing
- Optimises reconstruction of dermis and epidermis
- Improvement of surrounding skin (5)
- Less risk of maceration
- Clinically proven in over 36,000 patients (6)
- Pain-free dressing change (1,7,8)
- No trauma or disturbance to the wound bed
- UrgoTul® Absorb Border is indicated for the treatment of low-moderately exuding wounds
- Acute wounds: Minor burns, traumatic wounds, dermabrasions, post-operative wounds
- Chronic wounds: Arterial leg ulcers, mixed aetiology leg ulcers, and pressure ulcers
|8 x 8cm||10||550866||ELA660||386-7132|
|10 x 10cm||10||551014||ELA661||386-7140|
|13 x 13cm||10||550867||ELA662||386-7157|
|15 x 20cm||10||550868||ELA663||386-7165|
|20 x 20cm (Sacral)||5||550869||ELA664||386-7173|
*Delivery time: 5 days from receipt to order
Also available in a sacral version
Structure of the absorbent and adhesive foam dressing
Absorbent foam dressing with a silicone adhesive border
For the management of acute and chronic exuding wounds
- TLC healing matrix to optimise healing when in contact with the wound
- Absorbent layer
- Pain-free and atraumatic removal for the patient (1,7,8)
- 17% Less expensive than the average foam adhesive border dressing (9)
Patient Experiences using UrgoTul® Absorb Border
- (1) Benbow M., Iossen G. A clinical evaluation of Urgotul to treat acute and chronic wounds. Br J Nurs 2004: 13(2): 105-109.
- (2) Winter G.D. Formation of the scab and rate of epithelialisation of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-294.
- (3) Bernard F.X. et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipido-colloid dressing J Wound Care 2005; 14 (5): 215-220.
- (4) Urgotul®. Data on file, 2010. Urgo.
- (5) Fays S. et al. Leg ulcers and the Urgocell Non-Adhesive wound dressing. Br J Nurs 2005: 14 (11):S15-20.
- (6) White R., Cowan T., Glover D. Supporting evidence based practice: a clinical review of TLC technology. Published in JWC, March 2011.
- (7) Smith J. et al. Evaluation of Urgotul plus K-four compression for venous leg ulcers, Br J Nurs 2004: 13 (6): S20-28.
- (8) Meaume S., Téot L. et al. The importance of pain reduction through dressing selection in routine wound management. Journal of Wound Care, 2004; 13 (10).
- (9) IMS Wounds Data. Units split Period January 2013 - December 2013. (Mepilex Border, Allevyn Gentle Border, Allevyn Life, Allevyn Adhesive, Biatain Silicone, Aquacel Adhesive Border, Tegaderm Adhesive Border).